GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Repros Therapeutics Inc. (RPRX) [hlAlert]

Rating:
Hold RPRX

Repros Therapeutics Inc. (RPRX) rated Hold with price target $5 by Wedbush Morgan

Posted on: Wednesday,  Jul 1, 2009  3:25 PM ET by Wedbush Morgan

Repros Therapeutics Inc. (RPRX)
rated Hold with price target $5 by Wedbush Morgan.

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. The Company's principal drug, Proellex, is a selective blocker of the progesterone receptor and is being developed for the treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, or anemia associated with uterine fibroids and endometriosis. The second product candidate, Androxal, is a single isomer of clomiphene citrate and an orally active small molecule compound.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/1/2009 3:25 PM Hold
None
4.89 5.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy